你即將離開本站

並前往https://www.onclive.com/view/luspatercept-ammt-demonstrates-long-term-efficacy-in-lr-mds

Luspatercept-ammt Demonstrates Long-Term Efficacy in LR ...

Luspatercept, a first-in-class erythroidmaturation agent, ... lower-risk myelodysplastic syndromes (LR-MDS) and ring ... News release.

確定！ 回上一頁

查詢 「LR Class News」的人也找了：

  1. lloyd's register news
    2.
  2. lloyd's register of shipping
    3.
  3. lloyd's classification society
    4.
  4. lrqa news
    5.
  5. lr approval finder
    6.
  6. lr register
    7.
  7. lloyd's register newsletter
    8.
  8. lloyd's assurance
    9.